A combination flu and Covid-19 vaccine has passed the test in animals and can now move on to trials in humans. — AFP
American biotech firm Novavax said on May 10 (2021) that it had positive results from preclinical studies of a shot combining its influenza and Covid-19 vaccine candidates.
The study, now on a preprint server and awaiting peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
